This analysis showed that elevated expression of METTL3, HK2 or GLUT1 in CRC tissues predicted robustly shorter disease-free intervals, either as a linear (Fig. 7c-e) or categorized variable (Fig. 7f-h). The gene discussed is SLC2A1; the disease is colorectal carcinoma.